A case of Guillian-Barre syndrome following COVID-19 vaccination
This case is noteworthy due the association between the COVID-19 vaccination and GBS. This patient developed symptoms of GBS approximately a week after his COVID-19 vaccination. This was determined by his neurologist after a further history. Therefore, GBS should be considered as a possible side effect to the COVID-19 vaccination.
openaire +1 more source
Efgartigimod for Guillain-Barré syndrome: a retrospective analysis of efficacy and safety. [PDF]
Bi Z, Ye X, Liu P, Lu M, Liu H, Chen M.
europepmc +1 more source
Dengue infection causing acute Hypokalemic paralysis: A case series. [PDF]
Goyal KK, Shubhakaran KP.
europepmc +1 more source
Vogt-Koyanagi-Harada Disease with Oral Manifestations: A Rare Case Report. [PDF]
Rani N +4 more
europepmc +1 more source
The genotypic and phenotypic landscape of PDHA1-related pyruvate dehydrogenase complex deficiency. [PDF]
Merkevicius K +109 more
europepmc +1 more source
Capillary versus arterial blood gases. Accuracy, acceptability, and suitability for use during sleep studies to calibrate transcutaneous carbon dioxide measurement. [PDF]
Sheers NL +11 more
europepmc +1 more source
Case report on severe myelin oligodendrocyte glycoprotein antibody-associated disease relapse after ectopic pregnancy and laparoscopic medical abortion: relevance of peripheral inflammation for demyelinating disease activity. [PDF]
Smertinaite L +9 more
europepmc +1 more source
Clinical Spectrum and Prognostic Predictors of Guillain-Barré Syndrome: A Prospective Observational Study From South India. [PDF]
Ravichandran H +9 more
europepmc +1 more source
Non-COVID Admissions to the ICU After COVID Vaccination: A Multicenter Study. [PDF]
Havaldar AA +5 more
europepmc +1 more source
Combined Central and Peripheral Demyelination with a Favorable Outcome: A Case with 10-Year Follow-up. [PDF]
Koçak ÖK +3 more
europepmc +1 more source

